CIK 0001425205
- Accelerated filer
IOVANCE BIOTHERAPEUTICS, INC.
Sign in to watch- Ticker
- IOVA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 753254381
- Phone
- +1 650-260-7120
- Business address
- 825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
- Former names
- Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
- 4 Open-market buy Director bought 10,000,000 shares at $6.50 ($65,000,000)
- 4 Open-market buy Director bought 10,000 shares at $6.31 ($63,100)
- 4 Open-market buy Interim CEO & General Counsel bought 1,000 shares at $5.98 ($5,980)
- 4 Open-market buy Director bought 10,000 shares at $6.18 ($61,800)
- 4 Open-market buy Director bought 10,000 shares at $6.10 ($61,000)
- 4 Option exercise Director acquired 40,000 shares (option exercise)
- 4 Shares withheld for taxes Chief Medical Officer gave up 6,809 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Financial Officer gave up 9,346 shares (to pay taxes)
- 4 Shares withheld for taxes Chief Operating Officer gave up 9,346 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Open-market buy Director bought 20,000 shares at an average $6.82 ($136,400)
- 4 Open-market buy Director bought 7,500 shares at $6.75 ($50,588)
- 4 Open-market buy Director bought 10,000 shares at an average $6.80 ($67,978)
- 4 Open-market buy Interim CEO & General Counsel bought 1,000 shares at $6.44 ($6,440)
Page 9 of 18 · 352 filings